An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Vertex to Present at Cowen’s 43rd Annual Health Care Conference on March 7
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Vertex Pharmaceuticals (NASDAQ: VRTX) will present at Cowen's 43rd Annual Health Care Conference on March 7, 2023, at 2:50 p.m. ET. The event will feature a live webcast accessible via the Vertex website in the "Investors" section. Vertex is a leading biotechnology company known for developing transformative medicines for serious diseases, particularly cystic fibrosis. The company, founded in 1989 and headquartered in Boston, has a broad pipeline, including therapies for sickle cell disease and type 1 diabetes. Vertex has received recognition for being a top employer in the biotechnology sector.
Positive
None.
Negative
None.
BOSTON--(BUSINESS WIRE)--
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at Cowen’s 43rd Annual Health Care Conference on Tuesday, March 7, 2023 at 2:50 p.m. ET.
A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.
About Vertex
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule, cell and genetic therapies in other serious diseases where it has deep insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes, alpha-1 antitrypsin deficiency and Duchenne muscular dystrophy.
Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston'sInnovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 13 consecutive years on Science magazine's Top Employers list and one of Fortune’s Best Workplaces in Biotechnology and Pharmaceuticals and Best Workplaces for Women. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.
When will Vertex Pharmaceuticals present at the Cowen Health Care Conference?
Vertex Pharmaceuticals will present at the Cowen Health Care Conference on March 7, 2023, at 2:50 p.m. ET.
Where can I watch the Vertex Pharmaceuticals presentation?
The presentation can be viewed live on the Vertex Pharmaceuticals website in the "Investors" section.
What types of therapies does Vertex Pharmaceuticals develop?
Vertex Pharmaceuticals develops therapies primarily for cystic fibrosis and has a pipeline for other serious diseases, including sickle cell disease and type 1 diabetes.
What is the significance of Vertex Pharmaceuticals' presence at the Cowen Conference?
Vertex's participation at the Cowen Conference highlights its ongoing commitment to innovation and investment in biotechnology.
What is the stock symbol for Vertex Pharmaceuticals?
The stock symbol for Vertex Pharmaceuticals is VRTX.
